Cel Sci CVM
NYSE CVM
$2.09 +0.00 (+0.00%)
As of: Oct 2, 2026 · 11:59 AM EDT

Cel Sci (CVM) Selling, General & Administrative (2010 - 2026)

Updated

Cel Sci (CVM) reported Selling, General & Administrative of $1.91 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 9.1% from $1.75 million a year earlier and up 22.3% from the prior quarter.

Analysis

Cel Sci (CVM) Selling, General & Administrative (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Cel Sci's Selling, General & Administrative came in at $7.49 million, down 9.1% year-over-year; for FY2025 (ended Sep 30, 2025), it was $8.92 million, up 8.9% from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of -5.3% (FY2020 to FY2025).
  • By fiscal year, Selling, General & Administrative came in at $8.19 million in FY2024 (-9.0%), $9 million in FY2023 (-15.9%), $10.71 million in FY2022 (-18.2%) and $13.09 million in FY2021 (+11.8%).
  • Five-year quarterly Selling, General & Administrative spans a low of $1.56 million in fiscal Q2 2026 and a high of $3.18 million in fiscal Q4 2021.
  • Year over year, Selling, General & Administrative gained in three of the last eight quarters, with an average decline of 4.8%.
  • The high point for year-over-year Selling, General & Administrative in five years was fiscal Q4 2025 (growth of 41.8%); the low point was fiscal Q2 2026 (a decline of 34.5%).
  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $1.56 million (Q2 2026), $1.69 million (Q1 2026) and $2.33 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.43 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.63 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -3.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -5.65 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.75 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.92 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 3.41 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 582.20 Mn
10 Cel Sci 3.69 Mn -21.96 Mn - 1.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.91 Mn
Mar 31, 2026 1.56 Mn
Dec 31, 2025 1.69 Mn
Sep 30, 2025 2.33 Mn
Jun 30, 2025 1.75 Mn
Mar 31, 2025 2.38 Mn
Dec 31, 2024 2.46 Mn
Sep 30, 2024 1.64 Mn
Jun 30, 2024 1.97 Mn
Mar 31, 2024 2.45 Mn
Dec 31, 2023 2.13 Mn
Sep 30, 2023 2.20 Mn
Jun 30, 2023 2.45 Mn
Mar 31, 2023 2.09 Mn
Dec 31, 2022 2.26 Mn
Sep 30, 2022 2.49 Mn
Jun 30, 2022 2.43 Mn
Mar 31, 2022 3.03 Mn
Dec 31, 2021 2.76 Mn
Sep 30, 2021 3.18 Mn
API Access

Cel Sci Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CVM&period=max&api_key=YOUR_API_KEY